FILTER

FILTERED INTERVIEW RESULTS

Rob McEwen & Michael Meding

EXECUTIVE CHAIRMAN & CHIEF OWNER (RM), VICE PRESIDENT & GENERAL MANAGER (MM), MCEWEN COPPER, MCEWEN MINING
"Los Azules is the ninth largest undeveloped copper deposit in the world, and within McEwen Mining, it represents the largest value and greatest excitement in our portfolio of assets."

Dean McPherson

HEAD, BUSINESS DEVELOPMENT - GLOBAL MINING, TORONTO STOCK EXCHANGE AND TSX VENTURE EXCHANGE
"We have a world class mining ecosystem built on the fact that Canada is a mining country."

Carlos Leigh

REGIONAL CEO – LATIN AMERICA, DSI UNDERGROUND
"In one way or another, part of our business in Chile is usually related directly or indirectly with Codelco."

Cristián Correa

GENERAL MANAGER – CHILE, GEOTEC BOYLES BROS
"Through building long-term relationships with major clients they see the value in paying for safety and quality, which is what Geotec offers."

Gonzalo Morante

GERENTE GENERAL, WALSH PERÚ
Environmental consultant Walsh Perú increasingly serves the mining sector (Spanish interview).

Dan Etheredge

VICE PRESIDENT LATIN AMERICA, KLOHN CRIPPEN BERGER (KCB)
A discussion about global trends in tailings design and management.

Andrew Lye

VICE PRESIDENT, RESOLUTION COPPER
"Our proposed underground mine is expected to become the largest copper mine in North America, capable of producing up to 25% of US copper demand each year."

John Martin

VP OF SOUTHERN AFRICA, KAL TIRE’S MINING TIRE GROUP
Kal Tire provides and services mining tires to an expanding African market.

Peter De Leo

MANAGING DIRECTOR, LYCOPODIUM LIMITED
"Lycopodium is busier than ever, particularly in Africa, where we have 10 projects, in addition to about 10 other feasibility studies underway."

Sandeep Singh

PRESIDENT & CEO, OSISKO GOLD ROYALTIES
“We enjoy looking back with the hindsight that we gained royalty assets cheaply and without competition.”

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.

PARTNER EVENTS